GSDMD and Sepsis: Future studies will investigate neuroinflammation and intestinal barrier dysfunction via GSDMD regulation, leveraging existing sepsis pyroptosis evidence [51, 52]; and (2) although compound 2 reduces DC maturation and systemic inflammation, the precise mechanisms of its immunomodulatory effects—particularly caspase‐3/7‐dependent regulation of cellular immunity—require further investigation.